Decision Engine for 505(b)(2)

Identify 505(b)(2)
Opportunities in Days,
Not Months

Replace weeks of regulatory, IP, and formulation pre-work with structured, IND-ready outputs — from a single AI platform built by pharma functional experts.

Combines Orange Book + IP + regulatory cross-mapping with multi-path scenario modeling to deliver decision-grade outputs — not just data.

Sample Platform Output
Live
505(b)(2) Pathway EligibilityMolecule × Indication × Reference Drug mapping
IP Landscape & Freedom-to-OperatePatent expiry, exclusivity, Paragraph IV risk
Multi-Path Development SimulationCost, time, complexity across 3+ strategies
IND-Ready Documentation PackagePre-formatted regulatory documents & dossiers
Market & Competitive IntelligenceCommercial viability with comparator analysis
5
Structured Outputs
6
Domains Synthesized
Days
Not Months
FDA · EMA · MHRA
On-Premise
Who This Is For

Designed for teams making development decisions every day

If you're evaluating, developing, or commercializing assets via 505(b)(2) or hybrid pathways — this replaces your manual pre-work.

BD & Portfolio Strategy
Screen acquisition targets and pipeline assets for 505(b)(2) viability in hours, not weeks. Get decision-grade briefs, not slide decks.
Regulatory Affairs
Map clinical and regulatory precedent, identify reference drugs, and generate pathway assessments — pre-formatted for regulatory review.
Formulation & CMC
Evaluate reformulation feasibility alongside IP and regulatory constraints. See which formulations create the strongest 505(b)(2) filing position.
IP & Patent Strategy
Orange Book cross-mapping, patent expiry analysis, Paragraph IV risk scoring, and freedom-to-operate assessment — in one view.
Specialty Pharma Executives
Portfolio-level visibility across pipeline assets. Compare opportunities by cost, timeline, and IP risk without waiting for cross-functional inputs.
Clinical Development
Identify clinical study requirements based on referenced drug data and precedent, aligned with the regulatory pathway strategy.
Replace Guesswork with Structured Decisions

What changes when you
plug in rethink Tx

Not a dashboard. Not a data lake. A decision engine that replaces manual pre-work.

Instead of
  • Manual analysis across siloed databases
  • Weeks assembling regulatory precedent
  • Single development strategy per asset
  • Ad hoc drafts requiring extensive rework
  • IP, regulatory, and commercial reviewed separately
You Get
  • AI-assisted cross-domain workflows
  • Regulatory + clinical precedent mapped in hours
  • Multi-path scenario simulation per asset
  • IND-ready documentation from templates
  • Unified decision engine across all functions
The Platform

From molecule to development plan,
five integrated stages

Each stage powered by domain-specific AI agents that work in parallel — not sequentially.

Ideation
Screen molecules for 505(b)(2) eligibility. Map therapeutic areas, reference drugs, and pathway options.
Validation
Cross-functional assessment — regulatory, IP, formulation, and commercial — by a digital panel of domain experts.
Optimization
Simulate development strategies. Compare cost, time, and complexity across multiple pathways per asset.
Confirmation
Generate IND-ready documents, dossiers, and development plans from proven regulatory templates.
Execution
Collaborate across teams, functions, and partners with shared context and institutional memory.
What You Get

Concrete outputs that replace
weeks of functional pre-work

Not insights. Not summaries. Decision-grade deliverables your team can act on.

505(b)(2) Pathway Screening
Screen molecules against eligibility criteria. Map reference drugs, clinical precedent, and regulatory pathway options automatically.
IP & Regulatory Cross-Mapping
Orange Book, patent landscape, exclusivity windows, and Paragraph IV risk — cross-referenced with regulatory precedent in one view.
Multi-Path Strategy Simulation
Simulate 3+ development strategies per asset. Compare cost, timeline, and complexity tradeoffs with scenario modeling.
IND-Ready Documentation
Pre-formatted regulatory documents, development plans, and submission-ready dossiers generated from proven templates.
Cross-Team Collaboration
Shared workspace across regulatory, formulation, IP, commercial, and strategy — with persistent institutional memory.
Integrated Data Layer
FDA, EMA, MHRA, patent databases, and your proprietary data — connected, synthesized, and searchable from one interface.
The Paradigm Shift

Your AI Exoskeleton
from Idea to Market

A persistent system augmenting every function — not another tool to learn.

Manual Analysis
AI-Assisted Workflows
Augmenting regulatory, formulation, IP, commercial, and strategy functions with domain-specific AI agents.
Siloed Inputs
Unified Decision Engine
Parallel, multi-domain validation — regulatory, IP, formulation, and commercial assessed simultaneously.
Single Strategy
Multi-Path Simulation
Explore alternatives across cost, time, and complexity. Every asset gets 3+ development scenarios.
Weeks of Drafting
Ready-to-Use Outputs
Transform ad hoc drafts into IND-ready dossiers and structured development plans.
Infrastructure

Built on integrated regulatory
and IP datasets

Persistent system augmenting: Regulatory · IP · Formulation · Commercial · Strategy

Integrated FDA, EMA, and IP datasets with secure on-premise deployment. Your data never leaves your environment.

Deploy on Your Terms

Your infrastructure, your control

Your Process, Your Digital Twin
Persistent institutional memory for portfolio decisions. The system learns your workflow and gets smarter over time.
Every Data Source, One View
Private and public data — FDA, EMA, MHRA, patent databases, and your proprietary sources — connected and searchable.
Secure On-Premise Deployment
Dedicated infrastructure built around your workflow. No data leaves your environment. Your security team will approve this.

See what the output
actually looks like

Not a pitch. A real sample output — pathway screening, IP landscape, strategy simulation, and documentation — for a 505(b)(2) asset.

rethinktx.com · connect@rethinktx.com